Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modificati⦠read more
Healthcare
Medical Devices
25 years
USD
Exclusive to Premium users
$27.59
Price-1.18%
-$0.33
$394.471m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$120.801m
-
1y CAGR-
3y CAGR-
5y CAGR-$17.627m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.23
-
1y CAGR-
3y CAGR-
5y CAGR$111.309m
$169.822m
Assets$58.513m
Liabilities$32.582m
Debt19.2%
-4x
Debt to EBITDA-$3.546m
-
1y CAGR-
3y CAGR-
5y CAGR